A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.
Journal article
Thomas T. et al, (2024), Nat Immunol
A data science roadmap for open science organizations engaged in early-stage drug discovery.
Journal article
Edfeldt K. et al, (2024), Nature communications, 15
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Journal article
Pouwels KB. et al, (2024), Nature Communications, 15
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study
Journal article
Bešević J. et al, (2024), Journal of Epidemiology and Community Health, 78, 105 - 108
Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements
Journal article
Griffen EJ. et al, (2024), Wellcome Open Research, 9
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases
Journal article
Pagnamenta AT. et al, (2023), Genome Medicine, 15
Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity
Journal article
West CE. et al, (2023), Scientific Data, 10
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Journal article
Thompson KN. et al, (2023), Science translational medicine, 15
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Journal article
Wei J. et al, (2023), Nature Communications, 14
Supportive Evidence For The Potential For Novel Biodiscovery In Osteoarthritis Through The Stepup Oa Consortium
Journal article
Perry TA. et al, (2023), Osteoarthritis and Cartilage, 31, S353 - S354
COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas
Journal article
Wang D. et al, (2023), Nucleic Acids Research, 51, D896 - D905
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
Journal article
Aschenbrenner D. et al, (2022), Journal of Clinical Immunology
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
Journal article
Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Journal article
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Journal article
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Journal article
Wei J. et al, (2022), Nature Medicine
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Abani O. et al, (2022), The Lancet, 399, 665 - 676
Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins.
Journal article
Smilova MD. et al, (2022), Journal of chemical information and modeling, 62, 284 - 294